Literature DB >> 18458972

Epidemiology of infections due to nonpigmented rapidly growing mycobacteria diagnosed in an urban area.

J Esteban1, N Z Martín-de-Hijas, A-I Fernandez, R Fernandez-Roblas, I Gadea.   

Abstract

The objective was to determine the incidence, clinical significance, and epidemiology of the isolates of nonpigmented, rapidly growing mycobacteria (NPRGM) in Madrid, Spain. Patients with new isolates of NPRGM during 2005 were selected prospectively for review of clinical charts. Clinical significance was analyzed according internationally accepted criteria. Randomly amplified polymorphic DNA (RAPD) was used for the genotyping of the isolates. NPRGM were identified in 70 patients (1.51 cases/100,000 inhabitants). The species were M. abscessus (in 5 patients), M. chelonae (in 9), M. fortuitum (in 40), M. peregrinum (in 9), M. mageritense (in 5), M. mucogenicum (in 2), and M. alvei (in 1 patient). The isolates were clinically significant in 17 cases (24.3%, 0.39 cases/100,000 inhabitants): in 4 cases of M. abscessus, in 5 of M. chelonae, and in 9 of M. fortuitum. Only 10.7% of the respiratory isolates were significant, whereas 75% of the nonrespiratory ones were significant (p < 0.001). RAPD analysis showed no relationship among the 74 strains available for the study. No characteristic resistance pattern could be found, although 4 strains appeared to be resistant to amikacin. Significant isolates were mainly nonrespiratory ones. The most significant species was M. abscessus. No relationship between the various isolates was detected, ruling out interhuman transmission between these cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458972     DOI: 10.1007/s10096-008-0521-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

1.  Molecular identification by random amplified polymorphic DNA analysis of a pseudo-outbreak of Mycobacterium fortuitum due to cross-contamination of clinical samples.

Authors:  Alberto Ortiz; Jaime Esteban; Nieves Zamora
Journal:  J Med Microbiol       Date:  2007-06       Impact factor: 2.472

2.  Epidemiology of infection by nontuberculous mycobacteria. VII. Absence of mycobacteria in southeastern groundwaters.

Authors:  E C Martin; B C Parker; J O Falkinham
Journal:  Am Rev Respir Dis       Date:  1987-08

3.  Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.

Authors:  Bodil E Jönsson; Marita Gilljam; Anders Lindblad; Malin Ridell; Agnes E Wold; Christina Welinder-Olsson
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

4.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.

Authors:  N Martín-Casabona; A R Bahrmand; J Bennedsen; V Ostergaard Thomsen; M Curcio; M Fauville-Dufaux; K Feldman; M Havelkova; M L Katila; K Köksalan; M F Pereira; F Rodrigues; G E Pfyffer; F Portaels; J Rosselló Urgell; S Rüsch-Gerdes; E Tortoli; V Vincent; B Watt
Journal:  Int J Tuberc Lung Dis       Date:  2004-10       Impact factor: 2.373

6.  Pulsed-field gel electrophoresis study of Mycobacterium abscessus isolates previously affected by DNA degradation.

Authors:  Yansheng Zhang; Mitchell A Yakrus; Edward A Graviss; Natalie Williams-Bouyer; Christine Turenne; Amin Kabani; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

7.  Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital.

Authors:  J Esteban; R Fernández Roblas; J I García Cía; N Zamora; A Ortiz
Journal:  J Infect       Date:  2006-04-17       Impact factor: 6.072

8.  Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.

Authors:  Mark F Schinsky; Roger E Morey; Arnold G Steigerwalt; Michael P Douglas; Rebecca W Wilson; Margaret M Floyd; W Ray Butler; Maryam I Daneshvar; Barbara A Brown-Elliott; Richard J Wallace; Michael M McNeil; Don J Brenner; June M Brown
Journal:  Int J Syst Evol Microbiol       Date:  2004-09       Impact factor: 2.747

9.  Mycobacterium alvei sp. nov.

Authors:  V Ausina; M Luquin; M García Barceló; M A Lanéelle; V Lévy-Frébault; F Belda; G Prats
Journal:  Int J Syst Bacteriol       Date:  1992-10

10.  Failure to recognize rapidly growing mycobacteria in a proficiency testing sample without specific request--a wider diagnostic problem?

Authors:  A von Graevenitz; V Pünter-Streit
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

View more
  10 in total

1.  Prosthetic joint infection caused by Mycobacterium alvei in an elderly patient.

Authors:  Chen-Hsiang Lee; Huey-Ling You; Jun-Wen Wang; Ya-Fen Tang; Jien-Wei Liu
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

2.  Potentially pathogenic nontuberculous mycobacteria found in aquatic systems. Analysis from a reclaimed water and water distribution system in Mexico City.

Authors:  A I Castillo-Rodal; M Mazari-Hiriart; L T Lloret-Sánchez; B Sachman-Ruiz; P Vinuesa; Y López-Vidal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-30       Impact factor: 3.267

3.  Detection of Polyclonality among Clinical Isolates from Prosthetic Joint Infections.

Authors:  Marta De-la-Fuente; Marta Martinez-Perez; Iris Gonzalez-Pallares; Jaime Esteban
Journal:  J Clin Microbiol       Date:  2015-09-16       Impact factor: 5.948

4.  In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.

Authors:  R Fernández-Roblas; N Z Martín-de-Hijas; A I Fernández-Martínez; D García-Almeida; I Gadea; J Esteban
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

5.  Specific Proteins in Nontuberculous Mycobacteria: New Potential Tools.

Authors:  Patricia Orduña; Antonia I Castillo-Rodal; Martha E Mercado; Samuel Ponce de León; Yolanda López-Vidal
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

Review 6.  An Update on Global Tuberculosis (TB).

Authors:  Balkis A Talip; Roy D Sleator; Colm J Lowery; James S G Dooley; William J Snelling
Journal:  Infect Dis (Auckl)       Date:  2013-05-21

7.  Draft Genome Sequence of Mycobacterium mageritense DSM 44476T.

Authors:  Olivier Croce; Catherine Robert; Didier Raoult; Michel Drancourt
Journal:  Genome Announc       Date:  2014-05-01

8.  Effect of ciprofloxacin in the ultrastructure and development of biofilms formed by rapidly growing mycobacteria.

Authors:  María-Carmen Muñoz-Egea; María García-Pedrazuela; Ignacio Mahillo; Jaime Esteban
Journal:  BMC Microbiol       Date:  2015-02-04       Impact factor: 3.605

9.  Tattoo-Associated Cutaneous Mycobacterium mageritense Infection: A Case Report and Brief Review of the Literature.

Authors:  Yolanka Lobo; Karyn Lun
Journal:  Case Rep Dermatol       Date:  2021-11-23

10.  Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria.

Authors:  Jaime Esteban; Nieves Z Martín-de-Hijas; Teemu J Kinnari; Guillermo Ayala; Ricardo Fernández-Roblas; Ignacio Gadea
Journal:  BMC Microbiol       Date:  2008-10-17       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.